Published in Exp Cell Res on July 10, 1996
Mutations in the PPPY motif of vesicular stomatitis virus matrix protein reduce virus budding by inhibiting a late step in virion release. J Virol (2000) 2.97
In vitro analog of human bone marrow from 3D scaffolds with biomimetic inverted colloidal crystal geometry. Biomaterials (2008) 1.00
VLA-5-mediated adhesion to fibronectin accelerates hemin-stimulated erythroid differentiation of K562 cells through induction of VLA-4 expression. J Biol Chem (2009) 0.84
CD10 is a marker for cycling cells with propensity to apoptosis in childhood ALL. Br J Cancer (2002) 0.83
Differential regulation of the attachment of Kaposi's sarcoma-associated herpesvirus (KSHV)-infected human B cells to extracellular matrix by KSHV-encoded gB and cellular alphaV integrins. Cell Microbiol (2008) 0.81
Apoptotic death of hematopoietic tumor cells through potentiated and sustained adhesion to fibronectin via VLA-4. J Biol Chem (2009) 0.78
Modulation of Tumor Cell Survival, Proliferation, and Differentiation by the Peptide Derived from Tenascin-C: Implication of β1-Integrin Activation. Int J Cell Biol (2011) 0.77
Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia. Leukemia (2004) 3.59
Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia. Lancet (1998) 3.07
Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia. Blood (2000) 2.92
The venders of medicines advertised in eighteenth-century Bath newspapers. Med Hist (1975) 2.90
Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia. Leukemia (2009) 2.24
Mutations in the mu heavy-chain gene in patients with agammaglobulinemia. N Engl J Med (1996) 2.10
Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital. Leukemia (2000) 1.94
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapse. Leukemia (2004) 1.87
Herbalists and medical botanists in mid-nineteenth-century Britain with special reference to Bristol. Med Hist (1982) 1.73
Medicines advertised in eighteenth-century Bath newspapers. Med Hist (1976) 1.65
Comparative analysis of flow cytometry and polymerase chain reaction for the detection of minimal residual disease in childhood acute lymphoblastic leukemia. Leukemia (2004) 1.65
An essential role for BLNK in human B cell development. Science (1999) 1.64
Technique of controlled reperfusion of the transplanted lung in humans. Ann Thorac Surg (2000) 1.62
A novel monoclonal antibody BI-3C5 recognises myeloblasts and non-B non-T lymphoblasts in acute leukaemias and CGL blast crises, and reacts with immature cells in normal bone marrow. Leuk Res (1985) 1.61
Rationale and design of Total Therapy Study XV for newly diagnosed childhood acute lymphoblastic leukemia. Ann Hematol (2004) 1.57
Mutations in the human lambda5/14.1 gene result in B cell deficiency and agammaglobulinemia. J Exp Med (1998) 1.55
PITSLRE protein kinase activity is associated with apoptosis. Mol Cell Biol (1995) 1.51
Apical and basolateral endocytic pathways of MDCK cells meet in acidic common endosomes distinct from a nearly-neutral apical recycling endosome. Traffic (2000) 1.49
Childhood acute lymphoblastic leukaemia--current status and future perspectives. Lancet Oncol (2001) 1.48
Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia. Blood (1992) 1.42
Human B cell development. I. Phenotypic differences of B lymphocytes in the bone marrow and peripheral lymphoid tissue. J Immunol (1985) 1.41
Endocrine pancreatic tumors: factors correlated with survival. Ann Oncol (2005) 1.41
PAMELA measurements of cosmic-ray proton and helium spectra. Science (2011) 1.39
"Cytoplasmic" expression of nuclear antigens. Leukemia (1989) 1.38
The providers of medical treatment in mid-nineteenth-century Bristol. Med Hist (1980) 1.33
IL-2 adenovector-transduced autologous tumor cells induce antitumor immune responses in patients with neuroblastoma. Blood (1998) 1.33
Combination of cladribine and cytarabine is effective for childhood acute myeloid leukemia: results of the St Jude AML97 trial. Leukemia (2009) 1.33
Expression of chimeric antigen receptors in natural killer cells with a regulatory-compliant non-viral method. Cancer Gene Ther (2009) 1.32
Mutations in Igalpha (CD79a) result in a complete block in B-cell development. J Clin Invest (1999) 1.32
Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma. J Clin Invest (1985) 1.30
Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia. Blood (1996) 1.24
Expression of T-cell receptors TcR1 (gamma/delta) and TcR2 (alpha/beta) in the human intestinal mucosa. Immunology (1989) 1.24
Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia. J Exp Med (1993) 1.20
Natural killer cell engineering for cellular therapy of cancer. Tissue Antigens (2011) 1.18
Adhesion-dependent survival of normal and leukemic human B lymphoblasts on bone marrow stromal cells. Blood (1994) 1.14
Stroma-supported culture in childhood B-lineage acute lymphoblastic leukemia cells predicts treatment outcome. J Clin Invest (1996) 1.14
Passive transfer studies with type II collagen antibody in B10.D2/old and new line and C57Bl/6 normal and beige (Chediak-Higashi) strains: evidence of important roles for C5 and multiple inflammatory cell types in the development of erosive arthritis. Arthritis Rheum (1987) 1.14
Nineteenth-century American health reformers and the early nature cure movement in Britain. Med Hist (1988) 1.14
Comparative cytotoxicity of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia. J Clin Oncol (1996) 1.14
X-linked agammaglobulinemia: new approaches to old questions based on the identification of the defective gene. Immunol Rev (1994) 1.09
ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapy. Leukemia (2011) 1.08
Idiopathic myelofibrosis: a possible role for immune-complexes in the pathogenesis of bone marrow fibrosis. Br J Haematol (1981) 1.08
The cytoplasmic expression of CD3 antigens in normal and malignant cells of the T lymphoid lineage. J Immunol (1987) 1.07
Medically qualified naturopaths and the General Medical Council. Med Hist (1991) 1.07
Increased risk for CNS relapse in pre-B cell leukemia with the t(1;19)/TCF3-PBX1. Leukemia (2009) 1.07
An anomalous positron abundance in cosmic rays with energies 1.5-100 GeV. Nature (2009) 1.07
Female pills and the reputation of iron as an abortifacient. Med Hist (1977) 1.06
The vicissitudes of herbalism in late nineteenth- and early twentieth-century Britain. Med Hist (1985) 1.06
Hyper IgM syndrome associated with defective CD40-mediated B cell activation. J Clin Invest (1994) 1.05
Identification of novel markers for monitoring minimal residual disease in acute lymphoblastic leukemia. Blood (2001) 1.05
Assessment of the quality of life in chronic pancreatitis using Sf-12 and EORTC Qlq-C30 questionnaires. Dig Liver Dis (2007) 1.05
Interleukin-2 gene-modified allogeneic tumor cells for treatment of relapsed neuroblastoma. Hum Gene Ther (1998) 1.04
T lymphocyte regeneration after transplantation of T cell depleted allogeneic bone marrow. Clin Exp Immunol (1986) 1.04
Prognostic features in acute megakaryoblastic leukemia in children without Down syndrome: a report from the AML02 multicenter trial and the Children's Oncology Group Study POG 9421. Leukemia (2012) 1.03
Interleukin-4 induces programmed cell death (apoptosis) in cases of high-risk acute lymphoblastic leukemia. Blood (1994) 1.03
Composition of the helical internal components of influenza virus as revealed by immunogold labeling/electron microscopy. Virology (1992) 1.01
Ligation of CD38 suppresses human B lymphopoiesis. J Exp Med (1995) 1.01
Hyperdiploid acute lymphoblastic leukemia with 51 to 65 chromosomes: a distinct biological entity with a marked propensity to undergo apoptosis. Blood (1999) 0.99
Leukemia diagnosis and testing of complement-fixing antibodies for bone marrow purging in acute lymphoid leukemia. Blood (1986) 0.99
Prevalence and growth characteristics of malignant stem cells in B-lineage acute lymphoblastic leukemia. Blood (1997) 0.97
The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases. Leukemia (1989) 0.97
Glycosaminoglycans of the rat renomedullary interstitium: ultrastructural and biochemical observations. Exp Mol Pathol (1988) 0.97
Epidemiology, clinical features and diagnosis of gastroenteropancreatic endocrine tumours. Ann Oncol (2001) 0.96
Expression and activation of the nonreceptor tyrosine kinase Tec in human B cells. Blood (1998) 0.94
Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian epidemiological study: the NET management study. J Endocrinol Invest (2011) 0.94
Highly localized tracks of human immunodeficiency virus type 1 Nef in the nucleus of cells of a human CD4+ T-cell line. Proc Natl Acad Sci U S A (1993) 0.93
Impact of genetic variation in FKBP5 on clinical response in pediatric acute myeloid leukemia patients: a pilot study. Leukemia (2011) 0.92
Use of stroma-supported cultures of leukemic cells to assess antileukemic drugs. II. Potent cytotoxicity of 2-chloro-deoxyadenosine in acute lymphoblastic leukemia. Leukemia (1994) 0.92
New measurement of the antiproton-to-proton flux ratio up to 100 GeV in the cosmic radiation. Phys Rev Lett (2009) 0.92
Development of a regional flow cytometry center for diagnosis of childhood leukemia in Central America. Leukemia (2005) 0.91
Use of stroma-supported cultures of leukemic cells to assess antileukemic drugs. I. Cytotoxicity of interferon alpha in acute lymphoblastic leukemia. Leukemia (1993) 0.90
The renal antihypertensive endocrine function: its relation to cytochrome P-450. J Hypertens (1989) 0.89
Lineage relationship of chronic lymphocytic leukemia and hairy cell leukemia: studies with TPA. Leuk Res (1984) 0.88
Cardiopulmonary bypass and thyroid function: a "euthyroid sick syndrome". Ann Thorac Surg (1991) 0.88
CD38 ligation inhibits normal and leukemic myelopoiesis. Blood (2000) 0.88
Interleukin-4 variant (BAY 36-1677) selectively induces apoptosis in acute lymphoblastic leukemia cells. Blood (2001) 0.87
In vitro cytotoxicity of docetaxel in childhood acute leukemias. J Clin Oncol (1998) 0.87
Tandem application of flow cytometry and polymerase chain reaction for comprehensive detection of minimal residual disease in childhood acute lymphoblastic leukemia. Leukemia (1999) 0.86
Fas activates NF-kappaB and induces apoptosis in T-cell lines by signaling pathways distinct from those induced by TNF-alpha. Cell Death Differ (1997) 0.86
Prognostic factors in the acute lymphoid and myeloid leukemias of infants. Leukemia (1996) 0.86
Kinetics of T lymphocyte development. Curr Top Pathol (1989) 0.86
Cyclosporin A induces apoptosis in childhood acute lymphoblastic leukemia cells. Blood (1998) 0.85
CD38-mediated signaling events in murine pro-B cells expressing human CD38 with or without its cytoplasmic domain. J Immunol (1999) 0.85
Coding polymorphisms in CD33 and response to gemtuzumab ozogamicin in pediatric patients with AML: a pilot study. Leukemia (2008) 0.85
CD38 ligation in human B cell progenitors triggers tyrosine phosphorylation of CD19 and association of CD19 with lyn and phosphatidylinositol 3-kinase. J Immunol (1997) 0.85
Effective treatment of advanced-stage childhood lymphoblastic lymphoma without prophylactic cranial irradiation: results of St Jude NHL13 study. Leukemia (2009) 0.84
Age-related differences in leukemia biology and prognosis: the paradigm of MLL-AF4-positive acute lymphoblastic leukemia. Leukemia (2007) 0.83
Human leukocyte function-associated antigens on lympho-hemopoietic precursor cells. Eur J Immunol (1986) 0.83
New definition of remission in childhood acute lymphoblastic leukemia. Leukemia (2000) 0.83
Pancreatic involvement in systemic sarcoidosis. A case report. Dig Liver Dis (2004) 0.82
Effects of prolactin and growth hormone on growth and metamorphosis of tadpoles of the frog, Rana pipiens. Gen Comp Endocrinol (1969) 0.82
N-CAM (CD56) expression by CD34+ malignant myeloblasts has implications for minimal residual disease detection in acute myeloid leukemia. Leukemia (1993) 0.82
Expression of the adaptor protein BLNK/SLP-65 in childhood acute lymphoblastic leukemia. Leukemia (2004) 0.81
Vaginal secretions increase the likelihood of intermale aggression in Syrian hamsters. Physiol Behav (1993) 0.81
Functional behaviour and immunological phenotype of circulating B lymphocytes in multiple myeloma. Studies with pokeweed mitogen. Clin Exp Immunol (1984) 0.81
Simple methods for the rapid exchange of flow cytometric data between remote centers. Leukemia (2000) 0.81
Autoimmune pancreatitis: the classification puzzle. Adv Med Sci (2007) 0.80
Malignant hypertension in blacks. Malignant intrarenal arterial disease as observed by light and electron microscopy. Hum Pathol (1976) 0.80